Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.
-
New antibiotic shows promise against superbug blood infections
Disease control CompletedThis study tested whether an older antibiotic, temocillin, works as well as a stronger one, meropenem, for treating blood infections caused by drug-resistant bacteria. Over 300 adults took part, receiving either antibiotic for 7 to 14 days. The goal was to see if temocillin could…
Phase: PHASE3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for stroke patients: safer blood thinner may prevent second blockage
Disease control CompletedThis study tested two blood thinners, tirofiban and aspirin, in 240 stroke patients who also had a blocked or narrowed neck artery. The goal was to see which drug better prevents the artery from re-blocking after a procedure to open it, while also checking for bleeding risks. Res…
Phase: PHASE4 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Mediterranean diet shows promise in fatty liver fight
Disease control CompletedThis study looked at whether a Mediterranean diet, with or without added exercise, could help people with a type of fatty liver disease called MASLD. The goal was to see if the diet could reduce fat and scarring in the liver. 96 adults with confirmed MASLD took part. The approach…
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 12, 2026 13:40 UTC